Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Arcus Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 193
- +22 vs. Q1 2024
- Shares held
- 51.9M
- −875.9K (−1.7%) vs. Q1 2024
- Total value
- $790.9M
- −$205.9M (−20.7%) vs. Q1 2024
- New holders
- 43
- 62 more added
- Sold out
- 21
- 63 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −32,356−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −29,014−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −21,416−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −19,825−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −17,691−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −16,052−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,846−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −3,139−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,870−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,750−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −1,952−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |